Unicycive Therapeutics (UNCY) PT Lowered to $63 at Lucid Capital Markets
Tweet Send to a Friend
Lucid Capital Markets analyst Elemer Piros lowered the price target on Unicycive Therapeutics (NASDAQ: UNCY) to $63.00 (from $105.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
